BG
MRNA icon

Bellevue Group’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$34.2M Sell
1,238,668
-279,454
-18% -$7.71M 0.75% 34
2025
Q1
$43M Sell
1,518,122
-82,755
-5% -$2.35M 0.96% 25
2024
Q4
$66.6M Buy
1,600,877
+41
+0% +$1.71K 1.28% 23
2024
Q3
$107M Buy
1,600,836
+37,101
+2% +$2.48M 1.73% 15
2024
Q2
$186M Sell
1,563,735
-147,354
-9% -$17.5M 3.02% 10
2024
Q1
$182M Sell
1,711,089
-197,331
-10% -$21M 2.78% 8
2023
Q4
$190M Buy
1,908,420
+413,095
+28% +$41.1M 2.9% 7
2023
Q3
$154M Sell
1,495,325
-29,734
-2% -$3.07M 2.49% 8
2023
Q2
$185M Sell
1,525,059
-26,647
-2% -$3.24M 2.64% 7
2023
Q1
$238M Sell
1,551,706
-30,622
-2% -$4.7M 3.46% 6
2022
Q4
$284M Buy
1,582,328
+22,527
+1% +$4.05M 3.77% 5
2022
Q3
$184M Sell
1,559,801
-17,550
-1% -$2.08M 2.65% 6
2022
Q2
$225M Sell
1,577,351
-61,998
-4% -$8.86M 3.19% 5
2022
Q1
$282M Sell
1,639,349
-69,900
-4% -$12M 3.28% 5
2021
Q4
$434M Sell
1,709,249
-18,100
-1% -$4.6M 4.47% 1
2021
Q3
$665M Sell
1,727,349
-814,951
-32% -$314M 6.75% 1
2021
Q2
$597M Sell
2,542,300
-267,650
-10% -$62.9M 5.83% 1
2021
Q1
$368M Sell
2,809,950
-136,963
-5% -$17.9M 3.89% 2
2020
Q4
$308M Sell
2,946,913
-395,037
-12% -$41.3M 3.53% 3
2020
Q3
$236M Sell
3,341,950
-3,000
-0.1% -$212K 3.27% 6
2020
Q2
$215M Sell
3,344,950
-605,231
-15% -$38.9M 3.04% 9
2020
Q1
$118M Sell
3,950,181
-984,900
-20% -$29.5M 2.29% 11
2019
Q4
$96.5M Buy
4,935,081
+91,000
+2% +$1.78M 1.53% 16
2019
Q3
$77.1M Buy
4,844,081
+119,835
+3% +$1.91M 1.43% 19
2019
Q2
$69.2M Buy
+4,724,246
New +$69.2M 1.18% 27